Skip to main content
PAS 2024 Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Pre-Conference Ticketed Event
Pre-Conference Ticketed Event
APA Award Winner
APA Award Winner
APS Award Winner
APS Award Winner
ASPN Award Winner
ASPN Award Winner
SPR Award Winner
SPR Award Winner
On Demand Presentation
On Demand Presentation
Poster Icons
SPR Award Winner
SPR Award Winner
Back

Deb Palazzi, MD, MEd

Professor of Pediatrics, Infectious Diseases
Baylor College of Medicine
Houston, Texas, United States

Presentation(s):

  • PRO: VATS is the most effective initial intervention for moderate-to-large parapneumonic effusions and empyemas

    Saturday, May 4, 2024
    11:40 AM – 11:50 AM ET

    Disclosure(s): Agency for Healthcare Research and Quality (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Elsevier (Ongoing) (Products/Services: Intellectual Property including patent beneficiary and royalties); JAMA Pediatrics (Ongoing) (Products/Services: Board Member or Executive Role); Pediatric infectious Diseases Society (Ongoing) (Products/Services: Board Member or Executive Role); PEW Charitable Trust (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator)

  • PIDS Top Abstracts

    Monday, May 6, 2024
    8:00 AM – 9:30 AM ET

    Disclosure(s): Agency for Healthcare Research and Quality (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator); Elsevier (Ongoing) (Products/Services: Intellectual Property including patent beneficiary and royalties); JAMA Pediatrics (Ongoing) (Products/Services: Board Member or Executive Role); Pediatric infectious Diseases Society (Ongoing) (Products/Services: Board Member or Executive Role); PEW Charitable Trust (Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator)